| Revision as of 09:29, 31 October 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,084 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'CAS_number').← Previous edit | Revision as of 09:29, 31 October 2011 edit undoBeetstra (talk | contribs)Edit filter managers, Administrators172,084 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: '').Next edit → | ||
| Line 28: | Line 28: | ||
| <!--Identifiers--> | <!--Identifiers--> | ||
| | CAS_number |
| CAS_number = 1202526-59-7 | ||
| | ATC_prefix = none | | ATC_prefix = none | ||
| | ATC_suffix = | | ATC_suffix = | ||
Revision as of 09:29, 31 October 2011
Pharmaceutical compound| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized |
| Target | lymphotoxin alpha |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider | |
Pateclizumab is an immunomodulator. It binds to lymphotoxin alpha.
References
- World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 105" (PDF). WHO Drug Information. 25 (2).
 | This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it. |
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Misplaced Pages by expanding it. |